Treatment of Deep Venous Thrombosis With Low-Molecular-Weight Heparins
- 27 March 1995
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of Internal Medicine
- Vol. 155 (6), 601-607
- https://doi.org/10.1001/archinte.1995.00430060059007
Abstract
Research from JAMA Internal Medicine — Treatment of Deep Venous Thrombosis With Low-Molecular-Weight Heparins — A Meta-analysisKeywords
This publication has 9 references indexed in Scilit:
- Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysisBMJ, 1994
- Acenocoumarol and Heparin Compared with Acenocoumarol Alone in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1992
- Dose adjusted heparin treatment of deep venous thrombosis: a comparison of unfractionated and low molecular weight heparinEuropean Journal of Clinical Pharmacology, 1990
- Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study.Circulation, 1989
- Deep Vein Thrombosis of the Legs: New Therapy by Mean of Low Molecular Weight HeparinsJournal of International Medical Research, 1988
- SUBCUTANEOUS ADMINISTRATION OF A LOW MOLECULAR WEIGHT HEPARIN (CY 222) COMPARED WITH SUBCUTANEOUS ADMINISTRATION OF STANDARD HEPARIN IN PATIENTS WITH ACUTE DEEP VEIN THROMBOSISPublished by Georg Thieme Verlag KG ,1987
- Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviewsStatistics in Medicine, 1987
- Intravenous and Subcutaneous Administration of Fragmin in Deep Venous ThrombosisPathophysiology of Haemostasis and Thrombosis, 1986
- A Prospective Study of the Value of Monitoring Heparin Treatment with the Activated Partial Thromboplastin TimeNew England Journal of Medicine, 1972